N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide

C28H30F3N7O3 — CID 175046339

IUPACN-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide
SMILESCC(=O)c1ccc(NC(=O)N2CCN(c3nc(Nc4ccc(C5CNCCO5)cc4)ncc3C(F)(F)F)CC2)cc1
InChIInChI=1S/C28H30F3N7O3/c1-18(39)19-2-6-22(7-3-19)35-27(40)38-13-11-37(12-14-38)25-23(28(29,30)31)16-33-26(36-25)34-21-8-4-20(5-9-21)24-17-32-10-15-41-24/h2-9,16,24,32H,10-15,17H2,1H3,(H,35,40)(H,33,34,36)
InChIKeyVOCQVERSBKLSFT-UHFFFAOYSA-N
MW569.59 g/mol
LogP4.46
Rot. Bonds6

About N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide

N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide (PubChem CID 175046339) has the molecular formula C28H30F3N7O3 and a molecular weight of 569.59 g/mol. Its IUPAC name is N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide.

Molecular Properties

Compound NameN-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide
PubChem CID175046339
Molecular FormulaC28H30F3N7O3
Molecular Weight569.59 g/mol
Exact Mass569.24
IUPAC NameN-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide
SMILESCC(=O)c1ccc(NC(=O)N2CCN(c3nc(Nc4ccc(C5CNCCO5)cc4)ncc3C(F)(F)F)CC2)cc1
InChIInChI=1S/C28H30F3N7O3/c1-18(39)19-2-6-22(7-3-19)35-27(40)38-13-11-37(12-14-38)25-23(28(29,30)31)16-33-26(36-25)34-21-8-4-20(5-9-21)24-17-32-10-15-41-24/h2-9,16,24,32H,10-15,17H2,1H3,(H,35,40)(H,33,34,36)
InChIKeyVOCQVERSBKLSFT-UHFFFAOYSA-N
XLogP4.46
TPSA111.72 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500569.59
LogP ≤ 54.46
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide?
The IUPAC name of N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide (CID 175046339) is N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide.
What is the SMILES notation for N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide?
The canonical SMILES for N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide is CC(=O)c1ccc(NC(=O)N2CCN(c3nc(Nc4ccc(C5CNCCO5)cc4)ncc3C(F)(F)F)CC2)cc1.
What is the InChIKey of N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide?
The InChIKey is VOCQVERSBKLSFT-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H30F3N7O3/c1-18(39)19-2-6-22(7-3-19)35-27(40)38-13-11-37(12-14-38)25-23(28(29,30)31)16-33-26(36-25)34-21-8-4-20(5-9-21)24-17-32-10-15-41-24/h2-9,16,24,32H,10-15,17H2,1H3,(H,35,40)(H,33,34,36).
What are the key properties of N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide?
N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide has a molecular weight of 569.59 g/mol, XLogP of 4.46, 6 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-acetylphenyl)-4-[2-(4-morpholin-2-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]piperazine-1-carboxamide is sourced from PubChem (CID 175046339), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).